Effect of Intermittent Pneumatic Compression on Preventing Deep Vein Thrombosis Among Stroke Patients: A Systematic Review and Meta‐Analysis

D Zhang, F Li, X Li, G Du - Worldviews on Evidence‐Based …, 2018 - Wiley Online Library
D Zhang, F Li, X Li, G Du
Worldviews on Evidence‐Based Nursing, 2018Wiley Online Library
Background Deep vein thrombosis (DVT) and subsequent pulmonary embolism (PE) are
common complications of stroke. However, the effect of intermittent pneumatic compression
(IPC) for patients after stroke is uncertain. Objectives To assess the effectiveness and safety
of IPC in reducing the risk of DVT, PE, and mortality in stroke patients. Methods We searched
leading medical databases including Medline, EMBASE, Cochrane Library, Wanfang, CNKI,
and CBM, from inception to June 2, 2017. Studies comparing IPC with no IPC in stroke …
Background
Deep vein thrombosis (DVT) and subsequent pulmonary embolism (PE) are common complications of stroke. However, the effect of intermittent pneumatic compression (IPC) for patients after stroke is uncertain.
Objectives
To assess the effectiveness and safety of IPC in reducing the risk of DVT, PE, and mortality in stroke patients.
Methods
We searched leading medical databases including Medline, EMBASE, Cochrane Library, Wanfang, CNKI, and CBM, from inception to June 2, 2017. Studies comparing IPC with no IPC in stroke patients were included. Agreement was measured using simple agreement and kappa statistics. The rates of PE, DVT, and mortality were compared. The results were pooled using a fixed effects model to evaluate the differences between the IPC and control groups. If there was significant heterogeneity in the pooled result, a random effect model was used.
Results
We identified seven randomized controlled trials that included 3,551 stroke patients. The average calculated κ for the various parameters was κ = 0.96 (0.70–1). Overall, IPC significantly reduced the incidence of DVT in stroke patients (risk ratio [RR] = 0.50; 95% confidence interval [CI 0.27, 0.94]). At the same time, IPC increased IPC‐related adverse events (RR = 5.71; 95% CI [3.40, 9.58]). Though IPC was associated with a significant increase in survival by 4.5 days during 6 months of follow‐up (148–152 days; 95% CI [–0.2, 9.1]), there was a mean gain of only 0.9 days (26.7–27.6 days; 95% CI [2.1, 3.9]) in quality‐adjusted survival during the 6‐month follow‐up. Overall, sensitivity analyses did not alter these findings.
Linking Evidence to Action
This review provides an important basis for preventing DVT in stroke patients, especially in hemorrhagic stroke patients. IPC significantly reduces the risk of DVT and significantly improves survival in a wide variety of patients who are immobile after stroke. However, IPC does not significantly improve quality‐adjusted survival. Clinicians should take functional status and quality of life into consideration when making decisions for stroke patients.
Wiley Online Library
以上显示的是最相近的搜索结果。 查看全部搜索结果